Project Grant R35GM155273
- The National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training program (CFDA 93.859), awarded a $385,298 project grant to The Research Foundation for The State University of New York (Stony Brook University) for the period of February 1, 2025 to December 31, 2029. The project aims to develop a new biomimetic organic synthesis approach that leverages rationally designed pyridoxal-5'-phosphate (PLP)-mimicking catalysts to enable open-shell radical...
- The National Science Foundation (NSF) Chemical Synthesis Program awarded a $450,000 Project Grant to Professor William Chain at the University of Delaware (UDE) to develop new classes of reactions with aromatic compounds. The goal is to exploit weak bonds and temporarily elevate the reactivity of normally inert chemical compounds to facilitate the formation of a wide array of new carbon-based bonds, forging new cyclic frameworks that have applications in industrial, chemical, and medical...
- This $412,632 Project Grant award from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training program (CFDA 93.859), supports research to advance the biocatalytic synthesis of complex medicinal small molecules. The award, with a performance period from August 1, 2025 to July 31, 2030, will fund the development of computer-aided synthesis planning (CASP) tools to generalize known enzymatic reactions and predict routes for producing...
- This Project Grant award, provided by the National Science Foundation's Mathematical and Physical Sciences (CFDA 47.049) program, is supporting Professor Rashad Karimov of Auburn University in developing new catalytic methods to synthesize complex, non-aromatic heterocyclic molecules commonly found in medicines and natural products. The $590,557 award, with a performance period from September 1, 2025 to August 31, 2028, aims to improve the synthesis of these important molecular structures by...
- The National Science Foundation (NSF) Chemical Synthesis Program awarded a $575,000 Project Grant to the University of Kansas Center for Research Inc. to develop new photochemical reactions for creating valuable and structurally complex molecules efficiently and selectively. The project, titled "Exploiting Mechanistic Knowledge to Develop Selective and Robust Synthetic N,π*-Star Photochemistry," aims to (1) generate reactive ylides from strained rings through light-induced sensitized...
- The University of Illinois at Urbana-Champaign was awarded a $800,000 Project Grant by the National Science Foundation's Mathematical and Physical Sciences program (CFDA 47.049) to study the development of new methods for catalyzing the synthesis of high-value ring systems prominent in complex natural products, pharmaceutical and agrochemical compounds. The research, led by Professor Scott E. Denmark, aims to use selenium-based catalysts to anneal doubly functionalized reagents (featuring...
- The National Science Foundation Division of Chemistry awarded $525,000 to The Trustees of the University of Pennsylvania through the Mathematical and Physical Sciences federal grant program (CFDA 47.049) to support synthetic studies on herquline and lycopodium alkaloids from August 1, 2022 to July 31, 2025. Under this Project Grant, Professor Dirk Trauner of the University of Pennsylvania will develop new organoboron chemistry methods to synthesize the natural product herquline A, which has...
- This $400,000 Project Grant award from the National Science Foundation's (NSF) Mathematical and Physical Sciences program supports research by Professor Richmond Sarpong of the University of California, Berkeley on methods to insert reactive benzyne compounds into five-membered organic molecules to create new seven-membered ring structures. The planned studies will develop a streamlined approach for synthesizing complex organic molecules, providing a novel platform for multi-step organic...
- This Project Grant award of $259,966, funded by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), aims to develop new synthetic strategies to functionalize pyridine and diazine heterocycles. The goal is to introduce novel methods for directly and selectively installing a range of substituents on these heterocycles, which are widely used in medicinal chemistry. The project will explore three approaches: 1)...
- The National Science Foundation (NSF) Chemical Synthesis Program awarded a $592,818 Project Grant to Professor Brandon Ashfeld at the University of Notre Dame for the project "Exploiting Catalyst-Controlled Mechanistic Divergency in Cycloaddition Approaches to Oxindole Alkaloid Synthesis." The grant supports the development of new chemical reactions and synthetic tools to address challenges in the synthesis of complex, biologically relevant oxindole molecules. The research evaluates...
EXPANDING ACCESS TO MOLECULAR COMPLEXITY THROUGH NATURAL PRODUCT SYNTHESIS - THE DEVELOPMENT OF MODERN MEDICINES RELIES ON THE ABILITY TO ACCESS COMPOUNDS THAT ARE POTENT, SELECTIVE, AND IDEALLY CURATIVE. TO ACHIEVE THESE GOALS, CHEMISTS HAVE SOUGHT TO PREPARE EVERMORE COMPLEX STRUCTURES IN SEARCH OF NUANCED ACTIVITY AND SELECTIVITY PROFILES, ADVANCES DEPENDENT ON THE AVAILABILITY OF TOOLS AND STRATEGIES TO SYNTHESIZE SUCH COMPOUNDS IN AN ECONOMICAL AND SCALABLE FASHION. COMPLEX NATURAL PRODUCTS HAVE TRADITIONALLY INSPIRED THE DEVELOPMENT OF SUCH TOOLS, OFTEN ACTING AS KEY MILESTONES IN THE ADVANCEMENT OF ORGANIC SYNTHESIS AND AS VITAL MEDICINES IN THEIR OWN RIGHT. HOWEVER, AT THE APEX OF COMPLEXITY, THEIR STRUCTURES CONTINUE TO TEST THE LIMITS OF CURRENT CAPABILITIES: HIGHLY INTRICATE TARGETS ARE PREPARED ONLY THROUGH ENORMOUS EFFORT IN TERMS OF MAN-YEARS AND NUMBER OF SYNTHETIC OPERATIONS, OFTEN ONLY IN A TARGET-SPECIFIC MANNER. HERE, WE PROPOSE TO UTILIZE SUCH COMPOUNDS AS VEHICLES FOR THE DISCOVERY OF COMPLEXITY-GENERATING TOOLS AND TACTICS. WE OUTLINE APPROACHES TO SEVERAL FAMILIES OF NATURAL PRODUCTS BUILT UPON TWO DISTINCT COMPLEXITY-BUILDING STRATEGIES: DEAROMATIVE TRANSFORMATIONS OF READILY AVAILABLE AROMATIC COMPOUNDS AND DESYMMETRIZATION OF SIMPLE SYMMETRICAL PRECURSORS. IN THE FORMER CASE, AROMATIC FEEDSTOCKS - AVAILABLE AS PETROLEUM BYPRODUCTS OR FROM RENEWABLE BIOMASS - REPRESENT A VERSATILE SYNTHESIS PLATFORM GIVEN WELL-ESTABLISHED, PREDICTABLE MODES FOR THEIR FUNCTIONALIZATION. WE SEEK TO DEPLOY THESE MATERIALS IN COMPLEXITY-BUILDING DEAROMATIVE REACTIONS, DISRUPTING THEIR OTHERWISE STABLE AROMATIC SYSTEMS AND TRANSFORMING THEIR FLAT SP2-SCAFFOLDS INTO SP3-RICH COMPOUNDS CONTAINING MULTIPLE STEREOGENIC CENTERS. SPECIFICALLY, WE PROPOSE TO UTILIZE THE REGIODIVERGENT OXIDATIVE COUPLING OF SIMPLE BISPHENOLIC COMPOUNDS TO ACCESS THE STRUCTURAL COMPLEXITY INHERENT TO THE QUASSINOIDS, A FAMILY OF POTENT ANTICANCER TERPENOIDS. OUR SYNTHESIS PLATFORM WILL LEVERAGE THE BUILT-IN OXIDATION OF THE AROMATIC SYSTEMS TO ENCODE FOR MUCH OF THE SP3-SKELETAL OXIDATION IN THESE HIGHLY OXIDIZED TERPENOIDS, PROVIDING A UNIQUE MEANS TO ACCESS THESE TARGETS AND ANALOGUES, AND ILLUMINATE THEIR BIOLOGICAL MODE OF ACTION. IN A SYMMETRY-BREAKING TRANSFORMATION, WE WILL DEVELOP NEW PHOTOCHEMISTRY OF PYRIDINIUM IONS TO PROVIDE CONVENIENT ACCESS TO HIGHLY FUNCTIONALIZED CYCLOPENTANE BUILDING BLOCKS, IN PARTICULAR VIA ENANTIOSELECTIVE DESYMMETRIZATION OF SYMMETRICAL ALLYLIC CATION INTERMEDIATES. WE WILL APPLY THESE INTERMEDIATES TO THE ASYMMETRIC SYNTHESIS OF PACTAMYCIN-TYPE AMINOCYCLOPENTITOLS, HIGHLY POTENT ANTIPARASITIC AGENTS. WE WILL ALSO DEVELOP A RELATED APPROACH TO TWO SUBCLASSES OF THE LYCOPODIUM ALKALOIDS, WHICH INCLUDE CENTRAL NERVOUS SYSTEM-ACTIVE COMPOUNDS, BUILT UPON TWO SEQUENTIAL PHOTOCHEMICAL DEAROMATIZATIONS OF A SIMPLE QUINOLINE. OVERALL, SUCH DISCOVERIES WILL OPEN UP NEW AREAS OF COMPLEX CHEMICAL SPACE FROM SIMPLE AROMATIC OR SYMMETRICAL PRECURSORS, PROVIDING NATURAL PRODUCTS AND DESIGNED ANALOGUES FOR INTERROGATION OF BIOLOGICAL FUNCTION. THESE STUDIES WILL LEAD TO INNOVATIONS IN DEAROMATIZATION AND DESYMMETRIZATION CHEMISTRY, AFFORD NOVEL CHEMOTYPES FOR DISEASE TREATMENT, AND PROVIDE TOOL COMPOUNDS THAT MAY LEAD TO NEW DISCOVERIES IN BIOLOGY.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $328.0k | 5/7/25 | ||
| Not listed | $328.0k | 7/30/24 | ||
| Not listed | $328.0k | 7/30/24 |